Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals

Journal of Infectious Diseases

Volumn 213, Issue 10, 2016, Pages 1573-1578

  Fife, Kenneth H ^a,b,c   Mugwanya, Kenneth ^a   Thomas, Katherine K ^d   Baeten, Jared M ^a,d   Celum, Connie ^a,d   Bukusi, Elizabeth ^f,g,o   De Bruyn, Guy ^e,r   Mujugira, Andrew ^a   Vwalika, Bellington ^h,i,n   Wald, Anna ^a,d   Lingappa, Jairam R ^a   Lingappa, Jairam ^d   Campbell, Mary ^d   Corey, Lawrence ^d   Coombs, Robert W ^d   Hughes, James P ^d   Magaret, Amalia ^d   McElrath, M Juliana ^d   Morrow, Rhoda ^d   Mullins, James I ^j   Coetzee, David ^j   Fife, Kenneth ^k   Were, Edwin ^k   Essex, Max ^l   Makhema, Joseph ^l   Katabira, Elly ^m   Ronald, Allan ^m   Allen, Susan ^n,p,q   Kayitenkore, Kayitesi ⁿ   Karita, Etienne ⁿ   Cohen, Craig ^o   Kanweka, William ⁿ   Kapiga, Saidi ^p   Manongi, Rachel ^p   Farquhar, Carey ^d   John Stewart, Grace ^d   Kiarie, James ^d   Inambao, Mubiana ⁿ   Delany Moretlwe, Sinead ^q   Rees, Helen ^q   Gray, Glenda ^r   McIntyre, James ^r   Mugo, Nelly Rwamba ^d   more..

^a Department of Medicine ^*  (United States)

^b Deparment of Microbiology and Immunology   (United States)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f SANOFI PASTEUR   (France)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^h UNIVERSITY OF ZAMBIA   (Zambia)

ⁱ Zambia Emory HIV Research Project   (Zambia)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k INDIANA UNIVERSITY   (United States)

^l BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^m MAKERERE UNIVERSITY   (Uganda)

ⁿ EMORY UNIVERSITY   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p HARVARD UNIVERSITY   (United States)

^q UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^r UNIVERSITY OF THE WITWATERSRAND   (South Africa)

more..

Author keywords

Acyclovir; Antiretroviral therapy; Herpes simplex virus; Human immunodeficiency virus

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; PLACEBO;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; GENITAL ULCER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIRUS LOAD; VIRUS TRANSMISSION; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; HERPES GENITALIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; ULCER;

ACYCLOVIR; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COINFECTION; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; MALE; MIDDLE AGED; ULCER;

EID: 84969922434     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv765     Document Type: Article

References (28)

1. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133:447-54.
2. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10:251-61.
3. Karavellas MP, Lowder CY, Macdonald C, Avila CP Jr, Freeman WR. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998; 116:169-75.
4. Zegans ME, Walton RC, Holland GN, O'Donnell JJ, Jacobson MA, Margolis TP. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998; 125:292-300.
5. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
6. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
7. McClelland RS, Wang CC, Overbaugh J, et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 2002; 16:2425-30.
8. Serwadda D, Gray RH, Sewankambo NK, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003; 188:1492-7.
9. Tobian AA, Quinn TC. Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Curr Opin HIV AIDS 2009; 4:294-9.
10. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-39.
11. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-19.
12. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-71.
13. Ameli N, Bacchetti P, Morrow RA, et al. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS 2006; 20:1051-8.
14. Mayaud P, Nagot N, Konate I, et al. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect 2008; 84:332-7.
15. Posavad CM,Wald A, Kuntz S, et al. Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. J Infect Dis 2004; 190:693-6.
16. Fox PA, Barton SE, Francis N, et al. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med 1999; 1:10-8.
17. Couppie P, Sarazin F, Clyti E, et al. Increased incidence of genital herpes after HAART initiation: a frequent presentation of immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients. AIDS Patient Care STDS 2006; 20:143-5.
18. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000; 1:107-15.
19. Graham SM, Masese L, Gitau R, et al. Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 52:600-3.
20. Tobian AA, Grabowski MK, Serwadda D, et al. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy. J Infect Dis 2013; 208:839-46.
21. Lingappa JR, Baeten JM, Wald A, et al. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010; 375:824-33.
22. Jerome KR, Huang ML, Wald A, Selke S, Corey L. Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. J Clin Microbiol 2002; 40:2609-11.
23. Wald A, Huang ML, Carrell D, Selke S, Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: Comparison with HSV isolation in cell culture. J Infect Dis 2003; 188:1345-51.
24. Magaret AS, Wald A, Huang ML, Selke S, Corey L. Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa. J Clin Microbiol 2007; 45:1618-20.
25. Reynolds SJ, Makumbi F, Newell K, et al. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial. Lancet Infect Dis 2012; 12:441-8.
26. Mujugira A, Magaret AS, Celum C, et al. Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: A randomized controlled trial. J Infect Dis 2013; 208:1366-74.
27. Barnabas RV, Baeten JM, Lingappa JR, et al. Acyclovir prophylaxis reduces the incidence of herpes zoster among HIV-infected individuals: Results of a randomized clinical trial. J Infect Dis 2016; 213:551-5.
28. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIVinfected adults and adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://aidsinfo.nih.gov/ contentfiles/lvguidelines/adult-oi.pdf. Accessed 11 Nov 2015:O1-7.